| Net Cash Provided by (Used in) Operating Activities |
$9,200 |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$15,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
|
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
5,310,000 |
shares |
|
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
|
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$51,816 |
USD |
|
Q4 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$6,802 |
USD |
|
Q4 2025 |
Q2 2026 |
| Depreciation |
$2,100 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,802 |
USD |
|
Q4 2025 |
Q2 2026 |
| Additional Paid in Capital |
$45,969 |
USD |
|
Q4 2025 |
Q2 2026 |
| Amortization of Intangible Assets |
$2,100 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
Q2 2026 |